Showing results (61-70 of 103) with videos related to

Sort By:
Pageof 11
Blood|April 14, 2009
Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factorsKen-Hong Lim, Ayalew Tefferi, Terra L Lasho, et al.
Blood|April 30, 2005
The JAK2 V617F activating tyrosine kinase mutation is an infrequent event in both "atypical" myeloproliferative disorders and myelodysplastic syndromesDavid P Steensma, Gordon W Dewald, Terra L Lasho, et al.
Leukemia|April 7, 2006
JAK2 V617F is a rare finding in de novo acute myeloid leukemia, but STAT3 activation is common and remains unexplainedD P Steensma, R F McClure, J E Karp, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 6, 2012
Mucosal CD30-positive T-cell lymphoproliferations of the head and neck show a clinicopathologic spectrum similar to cutaneous CD30-positive T-cell lymphoproliferative disordersAndrew P Sciallis, Mark E Law, David J Inwards, et al.
Nature Structural & Molecular Biology|June 5, 2019
Structural basis for selective stalling of human ribosome nascent chain complexes by a drug-like moleculeWenfei Li, Fred R Ward, Kim F McClure, et al.
European Journal of Haematology|January 29, 2008
20+ yr without leukemic or fibrotic transformation in essential thrombocythemia or polycythemia vera: predictors at diagnosisAyalew Tefferi, Naseema Gangat, Alexandra P Wolanskyj, et al.
Leukemia|July 28, 2006
Janus kinase 2 (V617F) mutation status, signal transducer and activator of transcription-3 phosphorylation and impaired neutrophil apoptosis in myelofibrosis with myeloid metaplasiaR A Mesa, A Tefferi, T S Lasho, et al.
Chemical Research in Toxicology|September 24, 2011
Oxidative metabolism of a quinoxaline derivative by xanthine oxidase in rodent plasmaRaman Sharma, Heather Eng, Gregory S Walker, et al.
Bioorganic & Medicinal Chemistry Letters|December 9, 2009
Continued exploration of the triazolopyridine scaffold as a platform for p38 MAP kinase inhibitionKevin D Jerome, Paul V Rucker, Li Xing, et al.
Leukemia|August 5, 2006
Novel FISH probes designed to detect IGK-MYC and IGL-MYC rearrangements in B-cell lineage malignancy identify a new breakpoint cluster region designated BVR2R R Einerson, M E Law, H E Blair, et al.
Pageof 11